Malin Corporation | MLC - Market Capitalization


Malin Corporation reported EUR134.46M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 7M 2M Mar/2026
ALKERMES USD 7.93B 806M Aug/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Eurofins Scientific SE EUR 12.07B 699.59M Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
IQVIA Holdings USD 42.66B 10.41B Aug/2026
Lonza CHF 39.68B 980.61M Jun/2025
Malin Corporation EUR 133.52M 29.05M Aug/2026
Organon & Co USD 1.57B 290M Mar/2026
Ovoca Bio EUR 5.1M 3.93M Aug/2026
Revvity USD 14.23B 1.54B Aug/2026
Tectonic Therapeutic USD 580M 190M Mar/2026
Viatris USD 15.73B 1.39B Mar/2026
Xeris Pharmaceuticals USD 1000M 303M Mar/2026